International expert consensus on radical resection combined with intestinal autotransplantation for locally advanced pancreatic cancer
Authors: Ma, Tao; Wu, Guosheng; Schulick, Richard D; Li, Min; He, Jin; Lillemoe, Keith D; Zheng, Lei; Kleeff, Jorg; Rebelo, Artur; Bai, Xueli; Zhang, Qi; Zhang, Yu; Liu, Chaoxu; Dervenis, Christos; Michalski, Christoph W; Hank, Thomas; Qadan, Motaz; Wu, Wenming; Zhang, Taiping; Yang, Yinmo; Hao, Chunyi; Lou, Wenhui; Duan, Weihong; Chen, Yingtai; Yang, Yanling; Tai, Sheng; Cheng, Wei; Wei, Feng; Gao, Shunliang; Qiao, Guoliang; Xiao, Wenbo; Su, Xinhui; Zhang, Yuntao; Lu, Fangyan; Chen, Qi; Hu, Qida; Liang, Tingbo
Source journal: The British journal of surgery (2026-10-31)
DOI: 10.1093/bjs/znag147
Abstract
BACKGROUND: Radical resection combined with intestinal autotransplantation (RRCIA) has emerged as a potential curative option for highly selected patients with locally advanced pancreatic cancer (LAPC) and extensive mesenteric vascular involvement. This project aimed to develop expert consensus recommendations on indications, surgical strategies, perioperative management, and long-term care of RRCIA in patients with LAPC. METHODS: An international multidisciplinary panel of experts in pancreatic surgery, transplant surgery, medical oncology, radiation oncology, radiology, critical care, and perioperative care was convened. A modified Delphi process was used to develop consensus recommendations. The survey comprised six domains with a total of 20 questions covering patient selection, neoadjuvant therapy, surgical strategies, perioperative management, adjuvant therapy, and follow-up. Consensus was predefined as >/=80% agreement. RESULTS: Twenty consensus statements were developed. The quality of evidence was low for 17 statements and moderate for 3. Six recommendations were strong and 14 conditional. RRCIA was recommended only for highly selected patients at experienced high-volume centres following adequate neoadjuvant therapy and multidisciplinary evaluation. Surgical strategies should be individualized according to tumour location and vascular involvement. No definitive minimum residual bowel length was established, and preservation of well-perfused bowel and the ileocaecal valve was emphasized. Postoperative management should be tailored, including anticoagulation, nutritional support, selective implementation of enhanced recovery principles, adjuvant therapy, and structured long-term follow-up. CONCLUSION: This consensus provides the first international framework to guide the application of RRCIA for LAPC, emphasizing its use in carefully selected patients treated at experienced centres with multidisciplinary expertise.
Related topics
Related open access articles
- CHALLENGES IN THE DIAGNOSIS AND TREATMENT OF PATIENTS WITH COLORECTAL CANCER AND COVID-19 COINFECTION - CASE REPORT
- Facing COVID-19 via anti-inflammatory mechanism of action: Molecular docking and Pharmacokinetic studies of six anti-inflammatory compounds derived from Passiflora edulis
- Computational analysis by molecular docking of thirty alkaloid compounds from medicinal plants as potent inhibitors of SARS-CoV-2 main protease
- The use of non-invasive ventilation (NIV) in the treatment of patients with COVID-19
- Application of Nanotechnology in Treatment of COVID-19
- Nano Platforms in Combatting COVID-19: Unveiling Antiviral Strategies and Challenges
Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.